Emerging technologies for point-of-care management of HIV infection.

The global HIV/AIDS pandemic has resulted in 39 million deaths to date, and there are currently more than 35 million people living with HIV worldwide. Prevention, screening, and treatment strategies have led to major progress in addressing this disease globally. Diagnostics is critical for HIV prevention, screening and disease staging, and monitoring antiretroviral therapy (ART). Currently available diagnostic assays, which include polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and western blot (WB), are complex, expensive, and time consuming. These diagnostic technologies are ill suited for use in low- and middle-income countries, where the challenge of the HIV/AIDS pandemic is most severe. Therefore, innovative, inexpensive, disposable, and rapid diagnostic platform technologies are urgently needed. In this review, we discuss challenges associated with HIV management in resource-constrained settings and review the state-of-the-art HIV diagnostic technologies for CD4(+) T lymphocyte count, viral load measurement, and drug resistance testing.

[1]  Alan Ashworth,et al.  Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. , 2015, Annual review of medicine.

[2]  S. Hazen,et al.  The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. , 2015, Annual review of medicine.

[3]  P. Goodwin,et al.  Impact of the obesity epidemic on cancer. , 2015, Annual review of medicine.

[4]  T. Gilada,et al.  PREVENTION OF HIV-1 INFECTION WITH EARLY ANTIRETROVIRAL THERAPY: TREATMENT AS PREVENTION—TASP , 2014 .

[5]  Utkan Demirci,et al.  Advances in Plasmonic Technologies for Point of Care Applications , 2014, Chemical reviews.

[6]  Emily B Hanhauser,et al.  Nanostructured Optical Photonic Crystal Biosensor for HIV Viral Load Measurement , 2014, Scientific Reports.

[7]  Francoise F Giguel,et al.  Micro-a-fluidics ELISA for Rapid CD4 Cell Count at the Point-of-Care , 2014, Scientific Reports.

[8]  Ronald W. Davis,et al.  Digital microfluidic assay for protein detection , 2014, Proceedings of the National Academy of Sciences.

[9]  William J Ferguson,et al.  Vulnerability of point-of-care test reagents and instruments to environmental stresses: implications for health professionals and developers , 2013, Clinical chemistry and laboratory medicine.

[10]  Rashid Bashir,et al.  Microfluidic CD4+ and CD8+ T Lymphocyte Counters for Point-of-Care HIV Diagnostics Using Whole Blood , 2013, Science Translational Medicine.

[11]  D. Richman,et al.  Absence of detectable HIV-1 viremia after treatment cessation in an infant. , 2013, The New England journal of medicine.

[12]  R. Gray,et al.  Evaluation of current rapid HIV test algorithms in Rakai, Uganda. , 2013, Journal of virological methods.

[13]  Francoise F Giguel,et al.  Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate. , 2013, Small.

[14]  Amit Singhal,et al.  Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. , 2013, Biotechnology advances.

[15]  Ali Kemal Yetisen,et al.  Paper-based microfluidic point-of-care diagnostic devices. , 2013, Lab on a chip.

[16]  Savas Tasoglu,et al.  Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. , 2013, ACS nano.

[17]  P. Nath,et al.  Label-free biodetection using a smartphone. , 2013, Lab on a chip.

[18]  Kunal Sur,et al.  A point-of-care PCR test for HIV-1 detection in resource-limited settings. , 2013, Biosensors & bioelectronics.

[19]  Till Bärnighausen,et al.  Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment , 2013, Science.

[20]  Aydogan Ozcan,et al.  A personalized food allergen testing platform on a cellphone. , 2013, Lab on a chip.

[21]  N. Ford,et al.  SCALING UP ANTIRETROVIRAL THERAPY IN RESOURCE-LIMITED SETTINGS , 2002 .

[22]  Gundo Weiler,et al.  Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .

[23]  S. Laperche,et al.  Failures in the detection of HIV p24 antigen with the Determine HIV-1/2 Ag/Ab Combo rapid test. , 2012, The Journal of infectious diseases.

[24]  Molly M Stevens,et al.  Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. , 2012, Nature nanotechnology.

[25]  Jinghua Yu,et al.  Battery-triggered microfluidic paper-based multiplex electrochemiluminescence immunodevice based on potential-resolution strategy. , 2012, Lab on a chip.

[26]  Francoise F Giguel,et al.  Simple filter microchip for rapid separation of plasma and viruses from whole blood , 2012, International journal of nanomedicine.

[27]  T. Peter,et al.  Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations , 2012, PloS one.

[28]  R. Richards-Kortum,et al.  A paper and plastic device for performing recombinase polymerase amplification of HIV DNA. , 2012, Lab on a chip.

[29]  Jinghua Yu,et al.  3D origami-based multifunction-integrated immunodevice: low-cost and multiplexed sandwich chemiluminescence immunoassay on microfluidic paper-based analytical device. , 2012, Lab on a chip.

[30]  Aydogan Ozcan,et al.  Integrated rapid-diagnostic-test reader platform on a cellphone. , 2012, Lab on a chip.

[31]  Miguel Larguinho,et al.  Gold and silver nanoparticles for clinical diagnostics - From genomics to proteomics. , 2012, Journal of proteomics.

[32]  Utkan Demirci,et al.  Portable microfluidic chip for detection of Escherichia coli in produce and blood , 2012, International journal of nanomedicine.

[33]  Utkan Demirci,et al.  Efficient on-chip isolation of HIV subtypes. , 2012, Lab on a chip.

[34]  William C Miller,et al.  Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. , 2012, The Journal of infectious diseases.

[35]  R. Davalos,et al.  Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature. , 2012, Lab on a chip.

[36]  W. Stevens,et al.  Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa , 2012, Journal of the International AIDS Society.

[37]  David S Boyle,et al.  Emerging technologies for point-of-care CD4 T-lymphocyte counting. , 2012, Trends in biotechnology.

[38]  W. Qiu,et al.  Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. , 2011, Lab on a chip.

[39]  Y. K. Cheung,et al.  1 Supplementary Information for : Microfluidics-based diagnostics of infectious diseases in the developing world , 2011 .

[40]  William C Miller,et al.  The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study , 2011, The Lancet.

[41]  Umut A. Gurkan,et al.  Enumeration of CD4+ T-Cells Using a Portable Microchip Count Platform in Tanzanian HIV-Infected Patients , 2011, PloS one.

[42]  Umut A. Gurkan,et al.  Microengineering methods for cell-based microarrays and high-throughput drug-screening applications , 2011, Biofabrication.

[43]  Mehmet Toner,et al.  A microfabricated electrical differential counter for the selective enumeration of CD4+ T lymphocytes. , 2011, Lab on a chip.

[44]  Amy L. Gryshuk,et al.  Cell-Phone-Based Platform for Biomedical Device Development and Education Applications , 2011, PloS one.

[45]  Brian T Cunningham,et al.  Label-free cell-based assays using photonic crystal optical biosensors. , 2011, The Analyst.

[46]  Feng Xu,et al.  Miniaturized lensless imaging systems for cell and microorganism visualization in point‐of‐care testing , 2011, Biotechnology journal.

[47]  U. Unicef,et al.  Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .

[48]  Feng Xu,et al.  Advances in developing HIV-1 viral load assays for resource-limited settings. , 2010, Biotechnology advances.

[49]  Praphan Phanuphak,et al.  Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia , 2010, PloS one.

[50]  Hadi Shafiee,et al.  A Microfluidic System for Biological Particle Enrichment Using Contactless Dielectrophoresis , 2010 .

[51]  Lesley E Scott,et al.  Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. , 2010, The Journal of infectious diseases.

[52]  Indira Hewlett,et al.  Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. , 2010, The Journal of infectious diseases.

[53]  Helen H. Lee,et al.  Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. , 2010, The Journal of infectious diseases.

[54]  Shuqi Chen,et al.  A rapid and automated sample-to-result HIV load test for near-patient application. , 2010, The Journal of infectious diseases.

[55]  A. Calmy,et al.  Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. , 2010, The Journal of infectious diseases.

[56]  Bertrand Lemieux,et al.  Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings. , 2010, The Journal of infectious diseases.

[57]  M. Sano,et al.  Selective isolation of live/dead cells using contactless dielectrophoresis (cDEP). , 2010, Lab on a chip.

[58]  D. Holmes,et al.  Single cell impedance cytometry for identification and counting of CD4 T-cells in human blood using impedance labels. , 2010, Analytical chemistry.

[59]  Sau Yin Chin,et al.  Microfluidic CD4+ T-cell counting device using chemiluminescence-based detection. , 2010, Analytical chemistry.

[60]  G. Whitesides,et al.  Diagnostics for the developing world: microfluidic paper-based analytical devices. , 2010, Analytical chemistry.

[61]  Utkan Demirci,et al.  Rapid automated cell quantification on HIV microfluidic devices. , 2009, Lab on a chip.

[62]  Utkan Demirci,et al.  Quantum dot-based HIV capture and imaging in a microfluidic channel. , 2009, Biosensors & bioelectronics.

[63]  Z. Fox,et al.  Comparative Evaluation of the ExaVir Load Version 3 Reverse Transcriptase Assay for Measurement of Human Immunodeficiency Virus Type 1 Plasma Load , 2009, Journal of Clinical Microbiology.

[64]  J. V. van Oosterhout,et al.  Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria , 2009, Tropical medicine & international health : TM & IH.

[65]  David N Breslauer,et al.  Mobile Phone Based Clinical Microscopy for Global Health Applications , 2009, PloS one.

[66]  Emanuel Carrilho,et al.  Paper microzone plates. , 2009, Analytical chemistry.

[67]  M. Mine,et al.  Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. , 2009, Journal of virological methods.

[68]  Orawon Chailapakul,et al.  Electrochemical detection for paper-based microfluidics. , 2009, Analytical chemistry.

[69]  Ali Khademhosseini,et al.  Integrating microfluidics and lensless imaging for point-of-care testing , 2009, 2009 IEEE 35th Annual Northeast Bioengineering Conference.

[70]  Jesse V Jokerst,et al.  Integration of semiconductor quantum dots into nano-bio-chip systems for enumeration of CD4+ T cell counts at the point-of-need. , 2008, Lab on a chip.

[71]  Anthony S Fauci,et al.  An HIV vaccine--challenges and prospects. , 2008, The New England journal of medicine.

[72]  P. Yager,et al.  Point-of-care diagnostics for global health. , 2008, Annual review of biomedical engineering.

[73]  A. Ozcan,et al.  Ultra wide-field lens-free monitoring of cells on-chip. , 2008, Lab on a chip.

[74]  M. Fowler,et al.  Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. , 2007, American journal of obstetrics and gynecology.

[75]  Da Xing,et al.  Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends , 2007, Nucleic acids research.

[76]  N. Sewankambo,et al.  Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study , 2007, BMJ : British Medical Journal.

[77]  Mehmet Toner,et al.  Cell detection and counting through cell lysate impedance spectroscopy in microfluidic devices. , 2007, Lab on a chip.

[78]  G. Whitesides,et al.  Patterned paper as a platform for inexpensive, low-volume, portable bioassays. , 2007, Angewandte Chemie.

[79]  C. Franco-Paredes,et al.  Rapid HIV testing: A review of the literature and implications for the clinician , 2006, Current HIV/AIDS reports.

[80]  Atlanta,et al.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[81]  Christian Drosten,et al.  Ultrasensitive Monitoring of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5′ Long Terminal Repeat Domain , 2006, Clinical chemistry.

[82]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[83]  John T McDevitt,et al.  A Microchip CD4 Counting Method for HIV Monitoring in Resource-Poor Settings , 2005, PLoS medicine.

[84]  Xavier Anglaret,et al.  Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting , 2005, Journal of Clinical Microbiology.

[85]  L. Scott,et al.  Evaluation of Two Commercially Available, Inexpensive Alternative Assays Used for Assessing Viral Load in a Cohort of Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients from South Africa , 2005, Journal of Clinical Microbiology.

[86]  Samuel K Sia,et al.  Reagent-loaded cartridges for valveless and automated fluid delivery in microfluidic devices. , 2005, Analytical chemistry.

[87]  Mardge H. Cohen,et al.  Rapid HIV-1 testing during labor: a multicenter study. , 2004, JAMA.

[88]  C. Brennan,et al.  Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 Strains , 2004, Journal of Clinical Microbiology.

[89]  B. Clotet,et al.  Lack of Longitudinal Intrapatient Correlation between p24 Antigenemia and Levels of Human Immunodeficiency Virus (HIV) Type 1 RNA in Patients with Chronic HIV Infection during Structured Treatment Interruptions , 2004, Journal of Clinical Microbiology.

[90]  Wayne C Koff,et al.  HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.

[91]  Christine Katlama,et al.  Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. , 2003, The New England journal of medicine.

[92]  D. Kuritzkes,et al.  Performance Characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System , 2003, Journal of Clinical Microbiology.

[93]  Elizabeth Connick,et al.  Antiretroviral-drug resistance among patients recently infected with HIV. , 2002, The New England journal of medicine.

[94]  R. D’Aquila,et al.  Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  Christos J. Petropoulos,et al.  A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1 , 2000, Antimicrobial Agents and Chemotherapy.

[96]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[97]  C. Dolea,et al.  World Health Organization , 1949, International Organization.